1208893-80-4 Usage
Uses
Used in Pharmaceutical Industry:
2,6-dichloro-N-(1-Methyl-1H-imidazol-4-yl)pyrimidin-4-amine is used as a key intermediate in the synthesis of pharmaceutical drugs. Its diverse functional groups allow for the development of various drug candidates with potential therapeutic applications.
Used as an Antiviral Agent:
In the field of antiviral research, 2,6-dichloro-N-(1-Methyl-1H-imidazol-4-yl)pyrimidin-4-amine is employed for its potential antiviral properties. Its unique structure enables it to target specific viral enzymes or pathways, thereby inhibiting viral replication and reducing the severity of viral infections.
Used as an Anti-inflammatory Agent:
2,6-dichloro-N-(1-Methyl-1H-imidazol-4-yl)pyrimidin-4-amine also shows promise as an anti-inflammatory agent. Its ability to modulate inflammatory pathways and reduce the production of pro-inflammatory mediators makes it a valuable compound for the treatment of various inflammatory disorders.
Used in Drug Design and Optimization:
The versatile nature of 2,6-dichloro-N-(1-Methyl-1H-imidazol-4-yl)pyrimidin-4-amine makes it an ideal candidate for drug design and optimization. Its functional groups can be modified or combined with other chemical moieties to create novel drug candidates with improved pharmacological properties, such as increased potency, selectivity, and reduced side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 1208893-80-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,8,8,9 and 3 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1208893-80:
(9*1)+(8*2)+(7*0)+(6*8)+(5*8)+(4*9)+(3*3)+(2*8)+(1*0)=174
174 % 10 = 4
So 1208893-80-4 is a valid CAS Registry Number.
1208893-80-4Relevant articles and documents
2-(IMIDAZ0LYLAMIN0)-PYRIDINE DERIVATIVES AND THEIR USE AS JAK KINASE INHIBITORS
-
Page/Page column 66-67, (2010/04/03)
The present inv ention relates to compounds of Formula (I): or a pharmaceutically acceptable salt thereof, wherein Ring A is 5- or 6-membered heteroaryl, wherein said 5- or 6-membered heteroaryl is optionally substituted on carbon with one or more R6
HETEROCYCLIC JAK KINASE INHIBITORS
-
Page/Page column 87, (2010/04/27)
The present invention relates to compounds of Formula (I) and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds provide a treatment for myeloproliferative disorders and cancer
